相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High FSH dosing is associated with reduced live birth rate in fresh but not subsequent frozen embryo transfers
Erika M. Munch et al.
HUMAN REPRODUCTION (2017)
Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis
Theodora C. van Tilborg et al.
HUMAN REPRODUCTION (2017)
Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 2: The predicted hyper responder
Simone C. Oudshoorn et al.
HUMAN REPRODUCTION (2017)
Individualized follicle-stimulating hormone dosing and in vitro fertilization outcome in agonist downregulated cycles: a systematic review
Theodora C. van Tilborg et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2016)
A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept
Carlo Alviggi et al.
FERTILITY AND STERILITY (2016)
Reporting multiple cycles in trials on medically assisted reproduction
Irma Scholten et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2016)
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
Hesham G. Al-Inany et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial
Jessica Lefebvre et al.
FERTILITY AND STERILITY (2015)
Comparison of antimullerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials
Scott M. Nelson et al.
FERTILITY AND STERILITY (2015)
Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles
Valerie L. Baker et al.
FERTILITY AND STERILITY (2015)
Two new automated, compared with two enzyme-linked immunosorbent, antimullerian hormone assays
Scott M. Nelson et al.
FERTILITY AND STERILITY (2015)
Randomized, controlled, open-label, non-inferiority study of the CONSORT algorithm for individualized dosing of follitropin alfa
F. Olivennes et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2015)
Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group
A. M. Kolte et al.
HUMAN REPRODUCTION (2015)
Technical and performance characteristics of anti-Mullerian hormone and antral follicle count as biomarkers of ovarian response
Stamatina Iliodromiti et al.
HUMAN REPRODUCTION UPDATE (2015)
Improving the Reporting of Clinical Trials of Infertility Treatments (IMPRINT): modifying the CONSORT statement
Richard S. Legro et al.
HUMAN REPRODUCTION (2014)
Anti-Mullerian hormone: ovarian reserve testing and its potential clinical implications
Simone L. Broer et al.
HUMAN REPRODUCTION UPDATE (2014)
Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis
Simone L. Broer et al.
FERTILITY AND STERILITY (2013)
Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach
Simone L. Broer et al.
HUMAN REPRODUCTION UPDATE (2013)
Anti-Mullerian hormone versus antral follicle count for defining the starting dose of FSH
Vuong Thi Ngoc Lan et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2013)
The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial
Theodora C. van Tilborg et al.
BMC WOMENS HEALTH (2012)
Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles
Sesh Kamal Sunkara et al.
HUMAN REPRODUCTION (2011)
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria
A. P. Ferraretti et al.
HUMAN REPRODUCTION (2011)
A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count
K. Jayaprakasan et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2010)
What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders?
Murat Berkkanoglu et al.
FERTILITY AND STERILITY (2010)
The antral follicle count: practical recommendations for better standardization
Frank J. M. Broekmans et al.
FERTILITY AND STERILITY (2010)
Cetrorelix protocol versus gonadotropin-releasing hormone analog suppression long protocol for superovulation in intracyloplasmic sperm injection patients older than 40
Marco Sbracia et al.
FERTILITY AND STERILITY (2009)
Why do couples drop-out from IVF treatment? A prospective cohort study
M. F. G. Verberg et al.
HUMAN REPRODUCTION (2008)
Optimum number of oocytes for a successful first IVF treatment cycle
M. H. van der Gaast et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2006)
Preimplantation genetic screening reveals a high incidence of aneuploidy and mosaicism in embryos from young women undergoing IVF
EB Baart et al.
HUMAN REPRODUCTION (2006)
Short versus long gonadotropin-releasing hormone analogue suppression protocols for superovulation in patients ≥40 years old undergoing intracytoplasmic sperm injection
M Sbracia et al.
FERTILITY AND STERILITY (2005)
Chromosome 21 mosaic human preimplantation embryos predominantly arise from diploid conceptions
MG Katz-Jaffe et al.
FERTILITY AND STERILITY (2005)
Mulltiple birth resulting from ovarian stimulation for subfertility treatment
BCJM Fauser et al.
LANCET (2005)
Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial
ER Klinkert et al.
HUMAN REPRODUCTION (2005)
A poor response in the first in vitro fertilization cycle is not necessarily related to a poor prognosis in subsequent cycles
ER Klinkert et al.
FERTILITY AND STERILITY (2004)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
J Chang et al.
FERTILITY AND STERILITY (2004)
A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU/day in 'standard' patients undergoing IVF/ICSI treatment
B Popovic-Todorovic et al.
HUMAN REPRODUCTION (2003)
Quantitative transvaginal two- and three-dimensional sonography of the ovaries: reproducibility of antral follicle counts
GJ Scheffer et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2002)
A low number of retrieved oocytes at in vitro fertilization treatment is predictive of early menopause
EJ de Boer et al.
FERTILITY AND STERILITY (2002)
The variability of female reproductive ageing
ERT Velde et al.
HUMAN REPRODUCTION UPDATE (2002)
A prospective randomized clinical trial of differing starter doses of recombinant follicle-stimulating hormone (follitropin-beta) for first time in vitro fertilization and intracytoplasmic sperm injection treatment cycles
RF Harrison et al.
FERTILITY AND STERILITY (2001)
分享论文
